HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Involvement of leukotriene B4 in itching in a mouse model of ocular allergy.

Abstract
Itching of ocular allergy is alleviated but not completely relieved by H(1) histamine receptor antagonists, suggesting that histamine is not the sole itch mediator in ocular allergy. We investigated whether leukotriene B(4) (LTB(4)), a mediator of cutaneous itch, is involved in the itch of ocular allergy in mice. Mice were immunized by the repeated subcutaneous injections of ragweed pollen and alum into the caudal back, and given a subconjunctival injection of ragweed pollen extract into the palpebra for allergic challenge. Challenge with ragweed pollen extract markedly elicited ocular scratching in sensitized mice. The scratching was almost abolished by mast cell deficiency. The H(1) antagonist terfenadine partially inhibited scratching at a dose that almost completely suppressed plasma extravasation. Scratching was inhibited by the glucocorticoid betamethasone and the 5-lipoxygenase inhibitor zileuton at doses that inhibited the challenge-induced production of LTB(4). A subconjunctival injection of LTB(4) at doses 1/10,000 or less than that required for histamine elicited ocular scratching in naïve mice. The LTB(4) receptor antagonist ONO-4057 inhibited the ragweed pollen challenge-induced ocular scratching at doses that suppressed LTB(4)-induced ocular scratching. In addition to histamine, LTB(4) is involved in the ocular itching of pollen allergy. H(1) receptor antagonists with an inhibitory effect on the action and/or production of LTB(4) may have more potent anti-pruritic activity than selective H(1) antagonists.
AuthorsTsugunobu Andoh, Kazunari Sakai, Masahisa Urashima, Kayo Kitazawa, Azusa Honma, Yasushi Kuraishi
JournalExperimental eye research (Exp Eye Res) Vol. 98 Pg. 97-103 (May 2012) ISSN: 1096-0007 [Electronic] England
PMID22504036 (Publication Type: Journal Article)
CopyrightCopyright © 2012 Elsevier Ltd. All rights reserved.
Chemical References
  • Allergens
  • Glucocorticoids
  • Histamine H1 Antagonists, Non-Sedating
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Lipoxygenase Inhibitors
  • Phenylpropionates
  • ONO-LB 457
  • Leukotriene B4
  • Immunoglobulin E
  • Terfenadine
  • Histamine
  • zileuton
  • Hydroxyurea
Topics
  • Allergens (immunology)
  • Ambrosia
  • Animals
  • Conjunctivitis, Allergic (immunology, prevention & control)
  • Disease Models, Animal
  • Glucocorticoids (pharmacology)
  • Histamine (physiology)
  • Histamine H1 Antagonists, Non-Sedating (pharmacology)
  • Hydroxyurea (analogs & derivatives, pharmacology)
  • Immunoglobulin E (blood)
  • Immunoglobulin G (blood)
  • Immunosuppressive Agents (pharmacology)
  • Injections, Intraocular
  • Injections, Subcutaneous
  • Leukotriene B4 (physiology)
  • Lipoxygenase Inhibitors (pharmacology)
  • Male
  • Mast Cells (immunology)
  • Mice
  • Mice, Inbred ICR
  • Phenylpropionates
  • Pollen (immunology)
  • Terfenadine (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: